BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9239243)

  • 1. [Treatment of differentiated thyroid cancers of nodular type].
    Tourniaire J; Bernard MH; Bertholon-Gregoire M; Adeleine P; Berger-Dutrieux N
    Ann Endocrinol (Paris); 1997; 58(3):211-5. PubMed ID: 9239243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical picture of differentiated thyroid carcinoma in the T1 stage].
    Czarniecka A; Włoch J; Lange D
    Wiad Lek; 2001; 54 Suppl 1():225-33. PubMed ID: 12182030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
    Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
    Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary and follicular thyroid carcinoma.
    Schlumberger MJ; Torlantano M
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current state of the treatment of thyroid cancer].
    Paches AI; Liubaev VL; Shental' VV; Pustynskiĭ IN; Abdullin NA
    Vopr Onkol; 1998; 44(5):562-6. PubMed ID: 9884715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of thyroid cancers diagnosed histologically after surgery.
    Liaw KY; Chien YC
    J Formos Med Assoc; 1993 Apr; 92(4):312-6. PubMed ID: 8104578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postsurgical management of differentiated thyroid carcinoma.
    Mazzaferri EL; Robyn J
    Otolaryngol Clin North Am; 1996 Aug; 29(4):637-62. PubMed ID: 8844735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of differentiated carcinoma of the thyroid gland].
    Mimura T; Ito K
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1184-9. PubMed ID: 9379097
    [No Abstract]   [Full Text] [Related]  

  • 14. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma.
    Saadi H; Kleidermacher P; Esselstyn C
    Surgery; 2001 Jul; 130(1):30-5. PubMed ID: 11436009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differentiated thyroid carcinoma: survival and prognostic factors].
    Sastre Marcos J; Llamazares Iglesias O; Vicente Delgado A; Marco Martínez A; Cánovas Gaillemin B; Orradre Romero JL; Morlan López MÁ; López López J
    Endocrinol Nutr; 2011 Apr; 58(4):157-62. PubMed ID: 21419724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of locally aggressive well-differentiated thyroid cancer.
    Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
    Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
    Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
    Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.